Madrigal Pharma is an US-American stock, which might be unknown to many investors. This is no issue limited to Germany, but also in the US the company is widely unknown. However, a phenomenal price increase during the last year led to an increased attention.
Recently, even the analysts from Oppenheimer started to focus on the stock. Their analysis is quite moderate and ... Mehr lesen…
Ein Beitrag von Gideon Tanner.
